Table 2.
Factors | Reference (findings) |
---|---|
Patient variables |
|
Female gender |
Rougemont et al. (↑) |
Age>49 years |
Newman et al.* (↑); Freeman et al.**(↑) |
High monthly income |
Rougemont et al. (↓); Boyer et al. ([28] ; ↑) |
Education |
Freeman et al. (↑)* |
Binge drinking |
Boyer et al. ([32] ; ↓); Roux et al. (↓); Newman et al.(↓)* |
Drug use |
Freeman et al.(↓)* |
Tobacco use |
Freeman et al.(↓)* |
Lack of family support for adherence |
Boyer et al. ([32]; ↓); |
Experiencing discrimination and stigma |
Boyer et al. ([32]; ↓); |
Positive perception of treatment |
Roux et al. (↑) |
Being transferred-in to HIV clinic |
Mbopi-Keou (↑) |
Medication variables |
|
Switching regimen |
Boyer et al. ([32]; ↓); |
High motivation |
Roux et al.(↑) |
Using a reminder method |
Roux et al.(↑) |
Patient Provider Relationship |
|
Satisfaction with information provided by physician |
Roux et al.(↑) |
Disease characteristics |
|
Advanced stage of disease |
Rougemont et al. (↓); Roux et al.(↑) |
Increased duration on medication |
Roux et al.(↓); Freeman et al.(↑)*Mbopi-Keou (↑) |
Higher CD4¥ count at initiation of ART β |
Mbopi-Keou (↑) |
Health System/clinic Characteristics |
|
Cost of care/Having to pay for care |
Mosoko et al.(↓), Boyer et al. ([32] ; ↓) ; Boyer et al. ([28] ; ↓) Laurent et al. (↓) |
Increased distance from clinic |
Mosoko et al. (↓) |
Large hospital size |
Boyer et al. ([32]; ↓); |
No task shifting from physician to other staff | Boyer et al. ([32]; ↓); |
↓Reduces adherence; ↑increases adherence; * Cohort included participants from Cameroon, Burundi and the Democratic Republic of Congo; ** Cohort included females from Cameroon, Burundi and the Democratic Republic of Congo; ¥ CD4-positive-T-lymphocyte; β Antiretroviral therapy.